{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:22:43Z","timestamp":1738387363817,"version":"3.35.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12328-024-02078-8","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T16:12:58Z","timestamp":1733242378000},"page":"145-153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive genome analysis of hepatitis B virus using nanopore sequencing technology in patients with previously resolved infection and spontaneous reactivation without drug exposure"],"prefix":"10.1007","volume":"18","author":[{"given":"Shunsuke","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihito","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Kouyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"Naiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukinori","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Mochida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"2078_CR1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00535-016-1168-2","volume":"51","author":"S Mochida","year":"2016","unstructured":"Mochida S, Nakao M, Nakayama N, et al. Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies. J Gastroenterol. 2016;51:999\u20131010.","journal-title":"J Gastroenterol"},{"key":"2078_CR2","doi-asserted-by":"crossref","unstructured":"Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology. Japan Society of Hepatology Guidelines for the Management of Hepatitis B Virus Infection: 2019 update. Hepatol Res. 2020;50:892\u2013923.","DOI":"10.1111\/hepr.13504"},{"key":"2078_CR3","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s00535-017-1394-2","volume":"53","author":"M Nakao","year":"2018","unstructured":"Nakao M, Nakayama N, Uchida Y, et al. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol. 2018;53:752\u201369.","journal-title":"J Gastroenterol"},{"key":"2078_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/jmv.24115","volume":"87","author":"H Kamitsukasa","year":"2015","unstructured":"Kamitsukasa H, Iri M, Tanaka A, et al. Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection. J Med Virol. 2015;87:589\u2013600.","journal-title":"J Med Virol"},{"issue":"5","key":"2078_CR5","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s12328-020-01149-w","volume":"13","author":"N Obara","year":"2020","unstructured":"Obara N, Inoue J, Endo H, et al. Spontaneous reactivation of hepatitis B virus with S gene mutations in an elderly patient with diabetic nephropathy. Clin J Gastroenterol. 2020;13(5):914\u20139.","journal-title":"Clin J Gastroenterol"},{"issue":"4","key":"2078_CR6","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1007\/s12328-021-01423-5","volume":"14","author":"S Takakusagi","year":"2021","unstructured":"Takakusagi S, Takagi H, Yokoyama Y, et al. Spontaneous reactivation of hepatitis B virus with a frameshift mutation in the precore region in an elderly hepatitis B virus carrier with lifestyle-related diseases. Clin J Gastroenterol. 2021;14(4):1202\u201310.","journal-title":"Clin J Gastroenterol"},{"issue":"4","key":"2078_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s12328-024-01984-1","volume":"17","author":"T Sasaki","year":"2024","unstructured":"Sasaki T, Kakisaka K, Miyasaka A, et al. Spontaneous reactivation of hepatitis B virus with multiple novel mutations in an elderly patient with resolved hepatitis B virus infection. Clin J Gastroenterol. 2024;17(4):683\u201390.","journal-title":"Clin J Gastroenterol"},{"key":"2078_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1872-034X.2011.00860.x","volume":"41","author":"S Mochida","year":"2011","unstructured":"Mochida S, Takikawa Y, Nakayama N, et al. Diagnostic criteria of acute liver failure: a report by the intractable hepato-biliary diseases study group of Japan. Hepatol Res. 2011;41:805\u201312.","journal-title":"Hepatol Res"},{"key":"2078_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00535-012-0624-x","volume":"47","author":"K Sugawara","year":"2012","unstructured":"Sugawara K, Nakayama N, Mochida S. Acute liver failure in Japan: definition, classification, and prediction of the outcome. J Gastroenterol. 2012;47:849\u201361.","journal-title":"J Gastroenterol"},{"issue":"11","key":"2078_CR10","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/hepr.12238","volume":"44","author":"Y Uchida","year":"2014","unstructured":"Uchida Y, Kouyama JI, Naiki K, et al. Novel hepatitis B virus strain developing due to recombination between genotypes H and B strains isolated from a Japanese patient. Hepatol Res. 2014;44(11):1130\u201341.","journal-title":"Hepatol Res"},{"issue":"3","key":"2078_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/vaccines8030456","volume":"8","author":"T Inoue","year":"2020","unstructured":"Inoue T, Tanaka Y. Cross-protection of hepatitis B vaccination among different genotypes. Vaccines (Basel). 2020;8(3):456.","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"2078_CR12","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1136\/gutjnl-2021-324554","volume":"70","author":"D Kremsdorf","year":"2021","unstructured":"Kremsdorf D, Lekbaby B, Bablon P, et al. Alternative splicing of viral transcripts: the dark side of HBV. Gut. 2021;70(12):2373\u201382.","journal-title":"Gut"},{"issue":"2","key":"2078_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/hep.29082","volume":"66","author":"S Paul","year":"2017","unstructured":"Paul S, Dickstein A, Saxena A, et al. Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: a meta-analysis. Hepatology. 2017;66(2):379\u201388.","journal-title":"Hepatology"},{"issue":"6","key":"2078_CR14","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1136\/annrheumdis-2016-209973","volume":"76","author":"W Fukuda","year":"2017","unstructured":"Fukuda W, Hanyu T, Katayama M, et al. Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan. Ann Rheum Dis. 2017;76(6):1051\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2078_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jhep.2018.02.033","volume":"69","author":"HC Yang","year":"2018","unstructured":"Yang HC, Tsou HH, Pei SN, et al. Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection. J Hepatol. 2018;69(2):286\u201392.","journal-title":"J Hepatol"},{"key":"2078_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/hepr.13763","volume":"52","author":"S Mochida","year":"2022","unstructured":"Mochida S, Nakayama N, Terai S, et al. Diagnostic criteria for acute-on-chronic liver failure and related disease conditions in Japan. Hepatol Res. 2022;52:417\u201321.","journal-title":"Hepatol Res"},{"key":"2078_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0140-6736(90)91874-A","volume":"336","author":"WF Carman","year":"1990","unstructured":"Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990;336:325\u20139.","journal-title":"Lancet"},{"key":"2078_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3851\/IMP1771","volume":"16","author":"Y Ueda","year":"2011","unstructured":"Ueda Y, Marusawa H, Egawa H, et al. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation. Antivir Ther. 2011;16:479\u201387.","journal-title":"Antivir Ther"},{"key":"2078_CR19","doi-asserted-by":"publisher","first-page":"12850","DOI":"10.1128\/JVI.01499-10","volume":"84","author":"K Ito","year":"2010","unstructured":"Ito K, Qin Y, Guarnieri M, et al. Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site. J Virol. 2010;84:12850\u201361.","journal-title":"J Virol"},{"key":"2078_CR20","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/hep.27604","volume":"61","author":"R Salpini","year":"2015","unstructured":"Salpini R, Colagrossi L, Bellocchi MC, et al. Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. Hepatology. 2015;61:823\u201333.","journal-title":"Hepatology"},{"issue":"221","key":"2078_CR21","first-page":"400","volume":"14","author":"K Sakamoto","year":"2020","unstructured":"Sakamoto K, Umemura T, Ito K, et al. Virological factors associated with the occurrence of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection analyzed through ultradeep sequencing. J Infect Dis. 2020;14(221):400\u20137.","journal-title":"J Infect Dis"},{"key":"2078_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000047","volume":"7","author":"S Arasawa","year":"2023","unstructured":"Arasawa S, Takeda H, Takai A, et al. Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencing. Hepatol Commun. 2023;7: e0047.","journal-title":"Hepatol Commun"},{"key":"2078_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI8098","volume":"105","author":"P Soussan","year":"2000","unstructured":"Soussan P, Garreau F, Zylberberg H, et al. In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA. J Clin Invest. 2000;105:55\u201360.","journal-title":"J Clin Invest"},{"key":"2078_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0168-8278(02)00422-1","volume":"38","author":"P Soussan","year":"2003","unstructured":"Soussan P, Tuveri R, Nalpas B, et al. The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis. J Hepatol. 2003;38:343\u20138.","journal-title":"J Hepatol"},{"key":"2078_CR25","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1128\/JVI.02619-06","volume":"81","author":"M Mancini-Bourgine","year":"2007","unstructured":"Mancini-Bourgine M, Bayard F, Soussan P, et al. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients. J Virol. 2007;81:4963\u201372.","journal-title":"J Virol"},{"key":"2078_CR26","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/iub.108","volume":"60","author":"YW Lu","year":"2008","unstructured":"Lu YW, Ren YD, Bai J, et al. The spliced variant of hepatitis B virus protein, HBSP, interacts with Bcl-2\/Bcl-xL in vitro and induces apoptosis in HepG2 cells. IUBMB Life. 2008;60:700\u20132.","journal-title":"IUBMB Life"},{"key":"2078_CR27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bbrc.2006.10.002","volume":"351","author":"YW Lu","year":"2006","unstructured":"Lu YW, Tan TL, Chan V, et al. The HBSP gene is expressed during HBV replication, and its coded BH3-containing spliced viral protein induces apoptosis in HepG2 cells. Biochem Biophys Res Commun. 2006;351:64\u201370.","journal-title":"Biochem Biophys Res Commun"},{"key":"2078_CR28","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/jmv.21918","volume":"82","author":"J-Y Chen","year":"2010","unstructured":"Chen J-Y, Chen W-N, Liu L-L, et al. Hepatitis B spliced protein (HBSP) generated by a spliced hepatitis B virus RNA participates in abnormality of fibrin formation and functions by binding to fibrinogen \u03b3 chain. J Med Virol. 2010;82:2019\u201326.","journal-title":"J Med Virol"},{"key":"2078_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/1471-2407-14-282","volume":"14","author":"J-Y Chen","year":"2014","unstructured":"Chen J-Y, Chen W-N, Jiao B-Y, et al. Hepatitis B spliced protein (HBSP) promotes the carcinogenic effects of benzo [alpha] pyrene by interacting with microsomal epoxide hydrolase and enhancing its hydrolysis activity. BMC Cancer. 2014;14:282.","journal-title":"BMC Cancer"},{"key":"2078_CR30","first-page":"10","volume":"22","author":"O Rosmorduc","year":"1995","unstructured":"Rosmorduc O, Petit MA, Pol S, et al. In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA. Hepatology. 1995;22:10\u20139.","journal-title":"Hepatology"},{"key":"2078_CR31","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1099\/0022-1317-80-5-1253","volume":"80","author":"O Rosmorduc","year":"1999","unstructured":"Rosmorduc O, Sirma H, Soussan P, et al. Inhibition of interferon-inducible MxA protein expression by hepatitis B virus capsid protein. J Gen Virol. 1999;80:1253\u201362.","journal-title":"J Gen Virol"},{"issue":"5","key":"2078_CR32","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/ng.348","volume":"41","author":"Y Kamatani","year":"2009","unstructured":"Kamatani Y, Wattanapokayakit S, Ochi H, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009;41(5):591\u20135.","journal-title":"Nat Genet"},{"issue":"6","key":"2078_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039175","volume":"7","author":"N Nishida","year":"2012","unstructured":"Nishida N, Sawai H, Matsuura K, et al. Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS ONE. 2012;7(6): e39175.","journal-title":"PLoS ONE"},{"key":"2078_CR34","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/jmv.25011","volume":"90","author":"H Matsuda","year":"2018","unstructured":"Matsuda H, Hiramatsu K, Akazawa Y, et al. Genetic polymorphism and decreased expression of HLA class II DP genes are associated with HBV reactivation in patients treated with immunomodulatory agents. J Med Virol. 2018;90:712\u201320.","journal-title":"J Med Virol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02078-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-024-02078-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02078-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:16:49Z","timestamp":1738329409000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-024-02078-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2078"],"URL":"https:\/\/doi.org\/10.1007\/s12328-024-02078-8","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Satoshi MOCHIDA has received speaking fees or honoraria from Abbvie GK, Gilead Sciences Inc., Ohtsuka Pharmaceutical Co. Ltd., Torey Medical Co. Ltd, Eisai Co., Ltd. Asuka Pharmaceutical Co. Ltd., Chugai Pharmaceutical Co., Ltd., has received research grants from Abbvie GK, Eisai Co., Ltd. Sumitomo Pharma Co., Ltd. intellim Corporation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures were performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights"}},{"value":"Informed consent was obtained from the patient to publish the clinical and virological findings.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}